| Bioactivity | β-D-Galactose pentaacetate is a negative regulator of insulin with plasma membrane penetrating ability and can be hydrolyzed by intracellular esterases. β-D-Galactose pentaacetate inhibits leucine-induced insulin release in Wistar rat islets, potentially preventing excessive insulin release in pathological conditions[1]. |
| CAS | 4163-60-4 |
| Formula | C16H22O11 |
| Molar Mass | 390.34 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, stored under nitrogen, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture) |
| Reference | [1]. Malaisse WJ, et al. Inhibition of insulin release by alpha- and beta-D-galactose pentaacetate. Int J Mol Med. 1998 Sep;2(3):331-2. |
β-D-Galactose pentaacetate
CAS: 4163-60-4 F: C16H22O11 W: 390.34
β-D-Galactose pentaacetate is a negative regulator of insulin with plasma membrane penetrating ability and can be hydro
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.